This Week in Intellectual Property, August 4th
Rent Check The House Energy and Commerce Committee held a hearing on the state of coronavirus vaccine research and deployment. Significant focus was placed on selling the drug at nonprofit [...]
Ban the Bar (For Now, at Least)
Given the balkanized nature of bar examination policies across the U.S., only two general statements can be made about the examination which determines one’s ability to practice law: they’re inefficient [...]
Thoughts on the E&C Vaccine Hearing
The Tuesday before last, the House Energy and Commerce Committee held a hearing with executives from the major pharmaceutical companies AstraZeneca, Johnson & Johnson, Merck, Moderna, and Pfizer about the [...]
This Week in Intellectual Property, July 28th
News and Commentary Mark Bilby makes an impassioned case for why research should be available to make the publishing industry a means of human progress by allowing the free flow [...]
This Week in Intellectual Property, July 21st
News and Commentary In Forbes, Peter Suciu discusses latest social media crackdowns on copyright infringement, most recently by Twitch, pushed mostly by the RIAA in a manner reminiscent to the [...]
This Week in Intellectual Property, July 14th
Rent Check Two bills to subsidize the production of semiconductors in the United States have been introduced in the Senate. This legislation would be complemented by placing any resultant patents [...]
A Perfect Opportunity for a Patent Pool
Two bills to promote semiconductor manufacturing in the U.S., the American Foundries Act and the CHIPS for America Act, have been introduced in the Senate as part of an effort [...]
This Week in Intellectual Property, July 7th
Rent Check Gilead has released its pricing plan for the drug remdesivir, focusing exclusively on the welfare provided by the drug in a plan totally foreign to almost any other [...]
Estimating The Cost Of Delayed Generic Drug Entry To Medicaid
Delays in market entry of generic drugs are common. This study sought to identify the prevalence of delayed entry, the reasons for the delays, and the delays’ effects on Medicaid [...]
Gilead’s Gall
The best critiques of the patent system--both in theory and as it exists in practice--can be boiled down to a simple point: there is a world of difference between capturing [...]